Physician profile
Sandy Lieberman
NPI 1457360109
$4,414.89
in general payments reported to CMS, 2019-2025
7 companies · $83.48 in 2025
The $83.48 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.81 · 2020: $29.64 · 2021: $61.23 · 2023: $49.28 · 2024: $4,123 · 2025: $83.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,740 · Food and Beverage: $491 · Travel and Lodging: $25.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,740.00 |
| Food and Beverage | $490.75 |
| Travel and Lodging | $25.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $4,061.98 | 2024 | |
| Pfizer INC. | $107.88 | 2019-2023 | |
| Sanofi Pasteur INC. | $94.88 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $48.13 | 2024-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Cranial Technologies, INC | $41.72 | 2019-2024 | Doc Band |
| Glaxosmithkline, LLC. | $39.89 | 2025 | Bexsero, Penmenvy |
| Alk-Abello, INC | $20.41 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Lieberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.